Consequently, the tubastatin A-derived PROTACs disclosed in this study represent the first selective degraders of class IIb HDACs. Selective HDAC10 degradation has not yet been achieved, but it remains a key goal for expanding the toolbox of HDAC degraders. This goal may be achievable in the future by using acetylpolyamine mimetics as HDAC10-specific warheads. 17